MEP urges EMA to postpone adoption of data disclosure policy
This article was originally published in SRA
Executive Summary
Just days before the European Medicines Agency's management board is due to adopt its new policy on the disclosure of clinical trial data, the MEP who steered the landmark Clinical Trials Regulation through the European Parliament has called on the agency to postpone its decision1.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.